Beclin-1 and LC3B Expression in Canine Mast Cell Tumours: an Immuno-ultrastructural and Immunohistochemical Study of Autophagy

Overview

Journal Vet Q

Specialty Veterinary Medicine

Date 2024 Nov 1

PMID 39483060

Authors

Giovanna P Vicente

Leonardo Della Salda

Ricardo F Strefezzi

Affiliations

Soon will be listed here.

Abstract

Mast cell tumours (MCTs) are common malignant neoplasms in dogs, for which prognosis and therapeutic decisions are based on histological features and proliferation markers. Autophagy is a cellular catabolic process responsible for degrading cytoplasmic components to maintain homeostasis, alterations in which are frequently linked to tumour growth and progression. This study was conducted to investigate the occurrence of autophagy in canine MCTs and to verify its value as a prognostic indicator for dogs with the disease. Beclin-1 and LC3B expressions were investigated using immunohistochemistry, and autophagy was ultrastructurally characterised. The autophagic phenomenon was successfully visualised in neoplastic mast cells under transmission electron and immunoelectron microscopy. MCTs from dogs that died due to the disease showed higher positivity for Beclin-1 and dogs with MCTs presenting a LC3B granular immunohistochemical pattern had a significantly shorter post-surgical survival. The occurrence of autophagy is an indicator of poor prognosis. Future studies are needed to elucidate the specific mechanisms and open new opportunities to treatments targeting this cancer cell advantage.

References

He C, Klionsky D . Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009; 43:67-93. PMC: 2831538. DOI: 10.1146/annurev-genet-102808-114910. View

Galluzzi L, Pietrocola F, Bravo-San Pedro J, Amaravadi R, Baehrecke E, Cecconi F . Autophagy in malignant transformation and cancer progression. EMBO J. 2015; 34(7):856-80. PMC: 4388596. DOI: 10.15252/embj.201490784. View

Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, Mourmouras V . Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol. 2009; 41(4):503-12. DOI: 10.1016/j.humpath.2009.09.004. View

Kiupel M, Webster J, Bailey K, Best S, DeLay J, Detrisac C . Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Vet Pathol. 2010; 48(1):147-55. PMC: 8369849. DOI: 10.1177/0300985810386469. View

Liu J, Chang K, Lo C, Chu P, Liu C . Expression of autophagy-related protein Beclin-1 in malignant canine mammary tumors. BMC Vet Res. 2013; 9:75. PMC: 3639141. DOI: 10.1186/1746-6148-9-75. View

Fonseca-Alves C, Bento D, Torres-Neto R, Werner J, Kitchell B, Laufer-Amorim R . Ki67/KIT double immunohistochemical staining in cutaneous mast cell tumors from Boxer dogs. Res Vet Sci. 2015; 102:122-6. DOI: 10.1016/j.rvsc.2015.08.007. View

Zheng H, Zhao S, Xue H, Zhao E, Jiang H, Hao C . The Roles of Beclin 1 Expression in Gastric Cancer: A Marker for Carcinogenesis, Aggressive Behaviors and Favorable Prognosis, and a Target of Gene Therapy. Front Oncol. 2021; 10:613679. PMC: 7787063. DOI: 10.3389/fonc.2020.613679. View

Wu H, Hayashi T, Inoue M . Immunohistochemical expression of p27 and p21 in canine cutaneous mast cell tumors and histiocytomas. Vet Pathol. 2004; 41(3):296-9. DOI: 10.1354/vp.41-3-296. View

Levine B, Kroemer G . Biological Functions of Autophagy Genes: A Disease Perspective. Cell. 2019; 176(1-2):11-42. PMC: 6347410. DOI: 10.1016/j.cell.2018.09.048. View

10.

Thompson J, Yager J, Best S, Pearl D, Coomber B, TORRES R . Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices. Vet Pathol. 2010; 48(1):169-81. DOI: 10.1177/0300985810390716. View

11.

Schechter N, Murphy G . Serine proteinases are regionally segregated within mast cell granules. Lab Invest. 1995; 72(1):34-41. View

12.

Ganley I, Wong P, Gammoh N, Jiang X . Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. Mol Cell. 2011; 42(6):731-43. PMC: 3124681. DOI: 10.1016/j.molcel.2011.04.024. View

13.

Patnaik A, Ehler W, MacEwen E . Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol. 1984; 21(5):469-74. DOI: 10.1177/030098588402100503. View

14.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

15.

De Nardi A, Horta R, Fonseca-Alves C, Noleto de Paiva F, Linhares L, Firmo B . Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors. Cells. 2022; 11(4). PMC: 8870669. DOI: 10.3390/cells11040618. View

16.

Fimia G, Di Bartolomeo S, Piacentini M, Cecconi F . Unleashing the Ambra1-Beclin 1 complex from dynein chains: Ulk1 sets Ambra1 free to induce autophagy. Autophagy. 2010; 7(1):115-7. DOI: 10.4161/auto.7.1.14071. View

17.

Edinger A, Thompson C . Defective autophagy leads to cancer. Cancer Cell. 2004; 4(6):422-4. DOI: 10.1016/s1535-6108(03)00306-4. View

18.

Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T . Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res. 2007; 100(6):914-22. DOI: 10.1161/01.RES.0000261924.76669.36. View

19.

Gozuacik D, Kimchi A . Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004; 23(16):2891-906. DOI: 10.1038/sj.onc.1207521. View

20.

Massimini M, Palmieri C, De Maria R, Romanucci M, Malatesta D, De Martinis M . 17-AAG and Apoptosis, Autophagy, and Mitophagy in Canine Osteosarcoma Cell Lines. Vet Pathol. 2017; 54(3):405-412. DOI: 10.1177/0300985816681409. View